Orlex Hc

   
Google
 
Web NewDrugInformation.com

Orlex Hc


Drug - Orlex Hc
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OTIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetic Acid, Glacial; Hydrocortisone
Multiple ingredients are in alphabetical order.

Strength - 2%;1%
The potency of the active ingredient(s), Acetic Acid, Glacial; Hydrocortisone. May repeat for multiple part products.

Applicant - PROCTER AND GAMBLE
The firm name holding legal responsibility for Orlex Hc. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 086844
The FDA assigned number to Orlex Hc. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Orlex Hc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Orlex Hc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Orlex Hc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Orlex Hc is in. Format is RX, OTC, DISCN.

Applicant Full Name - Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co
The full name of the firm holding legal responsibility for the new application of Orlex Hc.

Orlex Hc